NL302572A - - Google Patents

Info

Publication number
NL302572A
NL302572A NL302572DA NL302572A NL 302572 A NL302572 A NL 302572A NL 302572D A NL302572D A NL 302572DA NL 302572 A NL302572 A NL 302572A
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL302572A publication Critical patent/NL302572A/xx

Links

NL302572D 1962-12-27 NL302572A (US20020095090A1-20020718-M00002.png)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5790262 1962-12-27
JP6427663 1963-10-29
JP5741963 1963-10-29
JP6250163 1963-11-22

Publications (1)

Publication Number Publication Date
NL302572A true NL302572A (US20020095090A1-20020718-M00002.png)

Family

ID=27463499

Family Applications (1)

Application Number Title Priority Date Filing Date
NL302572D NL302572A (US20020095090A1-20020718-M00002.png) 1962-12-27

Country Status (5)

Country Link
BE (1) BE641880A (US20020095090A1-20020718-M00002.png)
FR (1) FR3150M (US20020095090A1-20020718-M00002.png)
GB (1) GB1080599A (US20020095090A1-20020718-M00002.png)
LU (1) LU45106A1 (US20020095090A1-20020718-M00002.png)
NL (1) NL302572A (US20020095090A1-20020718-M00002.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2495608A1 (fr) * 1980-12-04 1982-06-11 Morelle Jean Nouveaux derives de l'acide aspartique et leurs usages
MX2007006171A (es) 2004-11-26 2007-10-08 Ucl Business Plc Composiciones que comprenden ornitina y acetato.
DK3263100T3 (da) 2009-04-03 2020-05-11 Ocera Therapeutics Inc L-ornithinphenylacetat og fremgangsmåder til fremstilling deraf
SG176675A1 (en) 2009-06-08 2012-01-30 Ucl Business Plc Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate
ES2720148T3 (es) 2010-10-06 2019-07-18 Ocera Therapeutics Inc Métodos de fabricación de fenilacetato de L-ornitina
JP6797117B2 (ja) 2014-11-24 2020-12-09 ユーシーエル ビジネス リミテッド アンモニア降下療法を用いた肝星細胞活性化関連疾患の処置
WO2017031131A1 (en) 2015-08-18 2017-02-23 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrate
WO2018208677A1 (en) 2017-05-11 2018-11-15 Ocera Therapeutics, Inc. Processes of making l-ornithine phenylacetate
CN107540413A (zh) * 2017-09-14 2018-01-05 精晶药业股份有限公司 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法

Also Published As

Publication number Publication date
FR3150M (fr) 1965-02-22
LU45106A1 (US20020095090A1-20020718-M00002.png) 1964-02-24
BE641880A (US20020095090A1-20020718-M00002.png) 1964-04-16
GB1080599A (en) 1967-08-23

Similar Documents

Publication Publication Date Title
BE630640A (US20020095090A1-20020718-M00002.png)
BE616548R (US20020095090A1-20020718-M00002.png)
BE614532A (US20020095090A1-20020718-M00002.png)
BE614986A (US20020095090A1-20020718-M00002.png)
BE631769A (US20020095090A1-20020718-M00002.png)
BE631669A (US20020095090A1-20020718-M00002.png)
BE631269A (US20020095090A1-20020718-M00002.png)
BE630619A (US20020095090A1-20020718-M00002.png)
BE630333A (US20020095090A1-20020718-M00002.png)
BE629944A (US20020095090A1-20020718-M00002.png)
BE629880A (US20020095090A1-20020718-M00002.png)
BE629872A (US20020095090A1-20020718-M00002.png)
BE629378A (US20020095090A1-20020718-M00002.png)
BE628946A (US20020095090A1-20020718-M00002.png)
BE628701A (US20020095090A1-20020718-M00002.png)
BE627733A (US20020095090A1-20020718-M00002.png)
BE627394A (US20020095090A1-20020718-M00002.png)
BE627343A (US20020095090A1-20020718-M00002.png)
BE622858A (US20020095090A1-20020718-M00002.png)
BE620262A (US20020095090A1-20020718-M00002.png)
BE616785A (US20020095090A1-20020718-M00002.png)
BE616490A (US20020095090A1-20020718-M00002.png)
BE616386A (US20020095090A1-20020718-M00002.png)
BE616166A (US20020095090A1-20020718-M00002.png)
BE615962A (US20020095090A1-20020718-M00002.png)